Cullgen

About Cullgen

Cullgen Inc. is a biotechnology company advancing targeted protein degradation therapies using novel E3 ligands and their uSMITE platform to create protein degraders for cancer and other debilitating diseases. Based in San Diego, California, the company focuses on expanding drug design to drug the undruggable and develops pipelines including non-opioid pain candidates and other therapeutics. Their science emphasizes protein degradation, degrader-antibody conjugates, and novel E3 ligands to treat cancer and other serious conditions.